Invention Grant
US08211913B2 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes
失效
5-芳基吡啶作为治疗糖尿病的11-β抑制剂
- Patent Title: 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes
- Patent Title (中): 5-芳基吡啶作为治疗糖尿病的11-β抑制剂
-
Application No.: US12372244Application Date: 2009-02-17
-
Publication No.: US08211913B2Publication Date: 2012-07-03
- Inventor: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
- Applicant: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Samuel H. Megerditchian
- Priority: EP04103639 20040728
- Main IPC: C07D213/02
- IPC: C07D213/02 ; A61K31/44
Abstract:
Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions.
Public/Granted literature
- US20090149503A1 NEW 5-ARYL PYRIDINES AS 11-BETA INHIBITORS FOR THE TREATMENT OF DIABETES Public/Granted day:2009-06-11
Information query
